Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ian Daniels

Showing results (21-30 of 30) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 30 results.
Journal for Immunotherapy of Cancer|February 10, 2022
PAD-2-mediated citrullination of nucleophosmin provides an effective target for tumor immunotherapyRuhul H Choudhury, Peter Symonds, Samantha J Paston, et al.
Frontiers in Immunology|April 25, 2022
Vaccine Can Induce CD4-Mediated Responses to Homocitrullinated Peptides <i>via</i> Multiple HLA-Types and Confer Anti-Tumor ImmunityKatherine Cook, Wei Xue, Suha Atabani, et al.
Oncoimmunology|May 10, 2019
T cell repertoire to citrullinated self-peptides in healthy humans is not confined to the HLA-DR SE alleles; Targeting of citrullinated self-peptides presented by HLA-DP4 for tumour therapyVictoria A Brentville, Peter Symonds, Katherine W Cook, et al.
Cancer Research|June 14, 2020
Engineering the Human Fc Region Enables Direct Cell Killing by Cancer Glycan-Targeting Antibodies without the Need for Immune Effector Cells or ComplementMireille Vankemmelbeke, Richard S McIntosh, Jia Xin Chua, et al.
Journal for Immunotherapy of Cancer|June 21, 2020
Combination vaccine based on citrullinated vimentin and enolase peptides induces potent CD4-mediated anti-tumor responsesVictoria A Brentville, Rachael L Metheringham, Ian Daniels, et al.
Frontiers in Immunology|December 22, 2022
Citrullinated glucose-regulated protein 78 is a candidate target for melanoma immunotherapyVictoria Anne Brentville, Peter Symonds, JiaXin Chua, et al.
Immunology|April 14, 2023
Immune responses to citrullinated and homocitrullinated peptides in healthy donors are not restricted to the HLA SE shared allele and can be selected into the memory poolRuhul H Choudhury, Ian Daniels, Poonam Vaghela, et al.
Journal for Immunotherapy of Cancer|July 29, 2021
Homocitrullination of lysine residues mediated by myeloid-derived suppressor cells in the tumor environment is a target for cancer immunotherapyKatherine W Cook, Wei Xue, Peter Symonds, et al.
Oncoimmunology|June 7, 2018
Targeting gp100 and TRP-2 with a DNA vaccine: Incorporating T cell epitopes with a human IgG1 antibody induces potent T cell responses that are associated with favourable clinical outcome in a phase I/II trialPoulam M Patel, Christian H Ottensmeier, Clive Mulatero, et al.
Nature Communications|December 4, 2025
Hologenomic analysis of rectal mucus sampling for detection of adenomatous polyps and colorectal cancerAndrew J Tock, Kamrun S Patel, Emma Morales-Walker, et al.
Pageof 3

Showing results (21-30 of 30) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 30 results.
Journal for Immunotherapy of Cancer|February 10, 2022
PAD-2-mediated citrullination of nucleophosmin provides an effective target for tumor immunotherapyRuhul H Choudhury, Peter Symonds, Samantha J Paston, et al.
Frontiers in Immunology|April 25, 2022
Vaccine Can Induce CD4-Mediated Responses to Homocitrullinated Peptides <i>via</i> Multiple HLA-Types and Confer Anti-Tumor ImmunityKatherine Cook, Wei Xue, Suha Atabani, et al.
Oncoimmunology|May 10, 2019
T cell repertoire to citrullinated self-peptides in healthy humans is not confined to the HLA-DR SE alleles; Targeting of citrullinated self-peptides presented by HLA-DP4 for tumour therapyVictoria A Brentville, Peter Symonds, Katherine W Cook, et al.
Cancer Research|June 14, 2020
Engineering the Human Fc Region Enables Direct Cell Killing by Cancer Glycan-Targeting Antibodies without the Need for Immune Effector Cells or ComplementMireille Vankemmelbeke, Richard S McIntosh, Jia Xin Chua, et al.
Journal for Immunotherapy of Cancer|June 21, 2020
Combination vaccine based on citrullinated vimentin and enolase peptides induces potent CD4-mediated anti-tumor responsesVictoria A Brentville, Rachael L Metheringham, Ian Daniels, et al.
Frontiers in Immunology|December 22, 2022
Citrullinated glucose-regulated protein 78 is a candidate target for melanoma immunotherapyVictoria Anne Brentville, Peter Symonds, JiaXin Chua, et al.
Immunology|April 14, 2023
Immune responses to citrullinated and homocitrullinated peptides in healthy donors are not restricted to the HLA SE shared allele and can be selected into the memory poolRuhul H Choudhury, Ian Daniels, Poonam Vaghela, et al.
Journal for Immunotherapy of Cancer|July 29, 2021
Homocitrullination of lysine residues mediated by myeloid-derived suppressor cells in the tumor environment is a target for cancer immunotherapyKatherine W Cook, Wei Xue, Peter Symonds, et al.
Oncoimmunology|June 7, 2018
Targeting gp100 and TRP-2 with a DNA vaccine: Incorporating T cell epitopes with a human IgG1 antibody induces potent T cell responses that are associated with favourable clinical outcome in a phase I/II trialPoulam M Patel, Christian H Ottensmeier, Clive Mulatero, et al.
Nature Communications|December 4, 2025
Hologenomic analysis of rectal mucus sampling for detection of adenomatous polyps and colorectal cancerAndrew J Tock, Kamrun S Patel, Emma Morales-Walker, et al.
Pageof 3